What is Levamisole?

Levamisol is a drug available for the treatment of parasitic worms infections and certain cancer. Due to the risk of potentially serious side effects, it was withdrawn from the market in several countries, including Canada and the United States. There are alternatives that your doctor can use to provide appropriate treatment for patients. It can also be available for veterinary use only in regions where it is not available for people. The veterinary use of the drug primarily focuses on its application as Dewormer. It can treat different worms infections in many different types. The drug helps the body effectively eliminate parasites from the intestine. In the treatment of cancer, levamisol seems to be an effective antineoplastic agent and may inhibit tumor growth, especially in combined therapy with other drugs.

There are significant risks with this drug. The first is the chance of an allergic reaction that can lead to skin rash, breathing and low blood pressure in some patients. Patients may also developt of bone marrow suppression and reduced immune function in levamisol use and will be less able to fight infections. The drug seems to compress the central nervous system and can cause neurological complications.

less serious side effects may include nausea and dry skin. They should be solved when the patient stops taking medication. Patients who notice symptoms such as tremor, slapping lips and confusion should talk to their doctors, because it may be signs, that the drug is active in the central nervous system. It is also important to be careful about the possible sources of infection when levamisol use, because it is easier to illness and heavier to fight infection.

previous liver, kidney or seizure disorders are contraindications for the use of this drug. Levamisol safety in pregnant women is unknown. Pregnant patients should discuss risks and benefits with the benefits of treatment before starting treatmentExpires doctors. If they experience pregnancy complications, including congenital defects, it is important to report them. Patients' data provide regulatory organs that they use to determine the warning with drugs. This may result in a decision to pull the medicine out of the market or to issue a black box warning alerting patients to the fact that the drug is dangerous but sufficiently beneficial to remain on the market.